SILVER SPRING, Md., May 26, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Thursday, the FDA issued warning letters to firms responsible for two popular flavored, disposable e-cigarette products—Shenzen Innokin Technology Co. Ltd., who make Esco Bars products, and Breeze Smoke … Read more
GAITHERSBURG, Md., May 26, 2023 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that Nuvaxovid™ (NVX-CoV2373) has been recommended for full Marketing Authorization (MA) for use as a primary series in individuals aged 12 and older and as a booster in individuals aged 18 … Read more
PRO1160 first patient dosed in the US China NMPA clearance for PRO1184 (rinatabart sesutecan, Rina-S) and PRO1160 to initiate clinical trials Rina-S preliminary clinical data is encouraging SUZHOU, China and WOODINVILLE, Wash., May 26, 2023 /PRNewswire/ — ProfoundBio, a clinical-stage biotechnology company focused on the development of novel antibody-based therapeutics, announced that dosing in the Phase … Read more
SUZHOU, China, and ROCKVILLE, Md., May 25, 2023 /PRNewswire/ — Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that 4 of its abstracts were selected for presentations at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting. These studies … Read more
DUBLIN, May 25, 2023 /PRNewswire/ — The “Allergy Immunotherapies Market: Global Market Size, Forecast, Insights, and Competitive Landscape” report has been added to ResearchAndMarkets.com’s offering. The global allergy immunotherapies market is expected to grow at a CAGR of around 9.4% during 2023-2030. Companies Mentioned Aimmune Therapeutics ALK-Abello A/S Allergy Therapeutics Anergis SA Biomay AG Circassia … Read more
Aufgeklärter molekularer Mechanismus hinter der Sicherheit und Wirksamkeit von Bersiporocin Bersiporocin befindet sich derzeit in einer klinischen Studie der Phase II zur Behandlung der idiopathischen Lungenfibrose SEOUL, Südkorea, 26. Mai 2023 /PRNewswire/ — Daewoong Pharmaceutical (CEO Lee Chang-jae und Jeon Sengho) gab am 25. Mai bekannt, dass der molekulare Mechanismus hinter der Sicherheit und Wirksamkeit … Read more
Combination expands footprint offering a global one-stop shop for streamlined chemical compound procurement and management services for drug discovery chemistry researchers. SAN DIEGO and ZOETERMEER, The Netherlands, May 25, 2023 /PRNewswire/ — eMolecules, Inc., an industry leading chemical compound search-and-fulfillment platform for early discovery chemistry research, today announced the acquisition of Specs Compound Handling B.V. … Read more
Zanidatamab data to be featured in oral presentation at ASCO 2023 Webcast to follow on June 2, 2023 at 6:45 p.m. CT DUBLIN, May 25, 2023 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) will host a webcast to review the zanidatamab biliary tract cancers (BTC) data being featured in an oral presentation at the 2023 American … Read more
DUBLIN, May 25, 2023 /PRNewswire/ — The “Technology Innovations and Growth Opportunities in Inhaled Therapeutics” report has been added to ResearchAndMarkets.com’s offering. Inhalation drug delivery involves administering drugs to the lungs through the mouth (pulmonary route) or nose (intranasal route), enabling them to bypass the blood-brain barrier. Small molecules have been the main focus for … Read more
SHANGHAI, May 25, 2023 /PRNewswire/ — 111, Inc. (NASDAQ: YI) (“111” or the “Company”), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial results for the first quarter ended March 31, 2023, before the U.S. market opens … Read more